Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -9.79x is 41% above its 5-year average of -16.73x, near the high end of its 5-year range (-26.42x–-4.29x).
5.63% above its 12-month average of -10.37x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -7.57x.
INTEREST COVERAGE RATIO
-9.79x
INTEREST COVERAGE RATIO AVG TTM
-10.37x
INTEREST COVERAGE RATIO AVG 3Y
-13.38x
INTEREST COVERAGE RATIO AVG 5Y
-16.73x
INTEREST COVERAGE RATIO AVG 10Y
-19.37x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+5.63%
CURRENT VS 3Y AVG
+26.82%
CURRENT VS 5Y AVG
+41.49%
CURRENT VS 10Y AVG
+49.46%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.31x
median of 511 covered companies
CURRENT VS SECTOR MEDIAN
-55.15%
vs the sector median at left
X4 Pharmaceuticals, Inc.
Market Cap
$259.85M
Interest Coverage Ratio
-9.79x
TTM Avg
-10.37x
3Y Avg
-13.38x
5Y Avg
-16.73x
Market Cap
$259.50M
Interest Coverage Ratio
-1805.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.73M
Interest Coverage Ratio
-530.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.31M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.00M
Interest Coverage Ratio
-360.54x
TTM Avg
23.12x
3Y Avg
23.12x
5Y Avg
1139.56x
Market Cap
$262.88M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$256.82M
Interest Coverage Ratio
N/A
TTM Avg
130.06x
3Y Avg
93.86x
5Y Avg
75.34x
Market Cap
$263.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.03M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. (XFOR) | $259.85M | -9.79x | -10.37x | -13.38x | -16.73x |
| Palisade Bio, Inc. (PALI)vs › | $259.50M | -1805.60x | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $258.73M | -530.37x | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $261.31M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $258.00M | -360.54x | 23.12x | 23.12x | 1139.56x |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $262.88M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.82M | N/A | 130.06x | 93.86x | 75.34x |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $263.43M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $264.03M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $266.62M | -4.86x | N/A | N/A | N/A |
Interest Coverage
-9.8x
Debt/Equity
0.50
Current Ratio
11.30
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -7.57x |
| 2026-03-31 | -9.52x |
| 2025-12-31 | -10.84x |
| 2025-09-30 | -12.19x |
| 2025-06-30 | -11.75x |
| 2025-03-31 | -4.29x |
| 2024-12-31 | -15.50x |
| 2024-09-30 | -14.29x |
| 2024-06-30 | -15.58x |
| 2024-03-31 | -19.90x |
| 2023-12-31 | -13.36x |
| 2023-09-30 | -16.65x |
| 2023-06-30 | -22.48x |
| 2023-03-31 | -26.42x |
| 2022-12-31 | -22.36x |
| 2022-09-30 | -19.80x |
| 2022-06-30 | -22.41x |
| 2022-03-31 | -23.85x |
| 2021-12-31 | -20.86x |
| 2021-09-30 | -20.78x |
| 2021-06-30 | -20.99x |
| 2021-03-31 | -20.13x |
| 2020-12-31 | -24.52x |
| 2020-09-30 | -24.36x |
| 2020-06-30 | -21.34x |
| 2020-03-31 | -18.12x |
| 2019-12-31 | -20.03x |
| 2019-09-30 | -18.85x |
| 2019-06-30 | -26.20x |
| 2019-03-31 | -26.16x |
| 2018-12-31 | -34.13x |
| 2018-09-30 | -57.74x |
| 2018-06-30 | -38.18x |
| 2018-03-31 | -36.15x |
| 2017-12-31 | -42.51x |
| 2017-09-30 | -47.32x |
| 2017-06-30 | -12.71x |
| 2017-03-31 | -5.72x |
| 2016-03-31 | -7.57x |
